ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Events

Lyra Therapeutics, Inc. (LYRA)

NASDAQ

$1.32

$-0.05

(-3.28%)

Lyra Therapeutics, Inc. (LYRA) Live Price Chart

Page last updated: 2026-02-12 21:22:00

Key Market Data

Market Cap	$2.34M
Open	$1.39
High	$1,100.00
Low	$1.32
Previous Close	$1.37
Price Change	$-0.05
Percentage Change	-3.28%
Volume	29K

Lyra Therapeutics, Inc. (LYRA) Stock Price Today

Lyra Therapeutics, Inc. (LYRA) is currently trading at $1.32 as of 2026-02-12 21:22:00, reflecting a -3.28% move ($-0.05) from the previous close.

In the short term, the stock has returned -3,015.87% over the past four weeks. Over the last 12 months, Lyra Therapeutics, Inc. has recorded a -86.56% price change, indicating a weak performance relative to the broader market.

Lyra Therapeutics, Inc. (LYRA) 7-Day Stock Price Changes

Over the past seven days, Lyra Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. During this period, the stock moved from its previous closing price of $1.71 to the latest recorded price of $1.32, reflecting an intraday change of -3.28%. Daily movements highlight shifts in trading volume (29,393), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, LYRA has delivered a -3,015.87% return over the past month and a -86.56% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Lyra Therapeutics, Inc. (LYRA)

You can buy and trade LYRA on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for LYRA and Execute Your Trade

Open the trading page, enter LYRA in the search bar, select the amount of LYRA you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Lyra Therapeutics, Inc. (LYRA)?

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Lyra Therapeutics, Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	87
Sector	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Website	https://lyratherapeutics.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Lyra Therapeutics, Inc.?

The latest trading price for Lyra Therapeutics, Inc. (Common Stock) is $ 1.32, compared with a previous closing price of $ 1.37. That means the stock has moved -3.28% so far today. Intraday price updates and recent trading activity for LYRA can be tracked on the live chart and quote section on this page.

2.Is Lyra Therapeutics, Inc. stock going up or down?

Looking at recent performances, LYRA has returned -3,015.87% over the past month, -81.94% over the last six months and -86.56% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Lyra Therapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does LYRA currently sit relative to its 52-week high and low?

In the most recent 52-week period, Lyra Therapeutics, Inc. has traded between a low of $ 1.32 and a high of $ 37.50. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether LYRA is currently nearer the top or the bottom of its one-year trading band.

4.How is Lyra Therapeutics, Inc. classified by sector and industry?

Lyra Therapeutics, Inc. is classified in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. In practice, this means Lyra Therapeutics, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing LYRA’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector could influence Lyra Therapeutics, Inc.’s performance.

5.Where is Lyra Therapeutics, Inc. listed and how large is it by market value?

Lyra Therapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 2.34M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Lyra Therapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does LYRA's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -18.56 summarises how much profit Lyra Therapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Lyra Therapeutics, Inc.'s financial performance over time?

To follow Lyra Therapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how LYRA is performing and how the market is responding.

8.When is Lyra Therapeutics, Inc. expected to report earnings?

Lyra Therapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for LYRA, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Lyra Therapeutics, Inc.'s earnings reports?

Lyra Therapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether LYRA is meeting, beating or missing expectations.

10.How can I stay informed about Lyra Therapeutics, Inc.'s results and guidance?

You can stay up to date on Lyra Therapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for LYRA on this page helps you see how new information is being reflected in the stock.

11.Does Lyra Therapeutics, Inc. pay a regular cash dividend to its shareholders?

Lyra Therapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor LYRA's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for LYRA?

Based on the latest earnings data, LYRA has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Lyra Therapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Lyra Therapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Lyra Therapeutics, Inc.?

Lyra Therapeutics, Inc. is a publicly traded company in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry within the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is LYRA valued in terms of P/E ratio and EPS?

Lyra Therapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -18.56. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Lyra Therapeutics, Inc.'s earnings. Comparing LYRA's P/E and EPS to those of other SURGICAL & MEDICAL INSTRUMENTS & APPARATUS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Lyra Therapeutics, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

Franklin Resources, Inc.

BEN

ChargePoint Holdings, Inc.

CHPT

Entergy Corporation

ETR

Goldman Sachs Group Inc.

Millrose Properties, Inc.

MRP

Top Gainers

Browse today's leading gainers in the US stock market

Haoxin Holdings Limited

HXHX

IPG Photonics Corporation

IPGP

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

LYRA-to-USD Calculator

Amount

LYRA

USD

1 LYRA = 1.32 USD